Teton Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-18,000
Closed -$490K 405
2021
Q3
$490K Hold
18,000
0.07% 282
2021
Q2
$308K Hold
18,000
0.04% 340
2021
Q1
$376K Hold
18,000
0.05% 292
2020
Q4
$412K Hold
18,000
0.06% 310
2020
Q3
$294K Hold
18,000
0.05% 314
2020
Q2
$244K Buy
+18,000
New +$209K 0.04% 341

Other funds holding XENT

Teton Advisors's XENT Position: Q4 2021 in Review

Teton Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 18,000 shares — an estimated $490K sold.

Teton Advisors first reported a position in XENT in Q2 2020 and held it in 6 quarters. The position peaked at $490K in Q3 2021. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.

  • Teton Advisors reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
  • Teton Advisors sold 18,000 Intersect ENT, Inc shares in Q4 2021, an estimated $490K.
  • Teton Advisors first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 6 quarters.
  • Teton Advisors's Intersect ENT, Inc position peaked at $490K in Q3 2021.
  • 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.

Based on Teton Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.